长链非编码RNA Morrbid在PTPN11(Shp2)E76K驱动的幼年型粒单核细胞白血病中的作用
约35%的幼年型粒单核细胞白血病(JMML)病例由PTPN11突变引起。本研究在小鼠模型中证实,敲除长链非编码RNA Morrbid可显著纠正Shp2E76K/+突变驱动的JMML相关髓系和红系细胞异常,包括总生存期;在携带PTPN11、KRAS和NRAS突变且MORRBID高表达的JMML患者中,总生存期较差。
要点
- Morrbid在Shp2E76K/+髓系细胞中显著失调,并参与JMML发病。
- 小鼠模型中敲除Morrbid可显著纠正JMML相关髓系和红系异常及总生存期。
- PTPN11、KRAS、NRAS突变且MORRBID高表达的JMML患者总生存期较差。
核心结论
- Morrbid参与JMML的发病机制。
研究设计与样本
- 研究采用Shp2E76K/+突变驱动JMML的小鼠模型,并分析JMML患者数据。
主要发现
- 在Shp2E76K/+-bearing髓系细胞中,Morrbid及其靶基因Bim显著失调。
- 小鼠模型中敲除Morrbid可显著纠正JMML相关的髓系和红系细胞异常,包括总生存期。
- 携带PTPN11、KRAS和NRAS突变且MORRBID高表达的JMML患者总生存期较差。
关键数值与推荐
- PTPN11突变约占JMML病例的35%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in PTPN11, which encodes the protein tyrosine phosphatase SHP2, contribute to ∼35% of cases of juvenile myelomonocytic leukemia (JMML). A common clinical picture in children with JMML is that it presents as a constitutive hyperinflammatory syndrome, partially reminiscent of chronic myelomonocytic leukemia in adults. Thus, a component of JMML is associated with a hyperinflammatory state and abundant innate immune cells such as neutrophils and monocytes. Recently, we showed that the evolutionarily conserved mouse lncRNA Morrbid is specifically expressed in myeloid cells and uniquely represses the expression of the proapoptotic gene Bim to regulate the lifespan of myeloid cells. However, its role in JMML has not been investigated. In this study, we characterized the role of Morrbid and its target Bim, which are significantly dysregulated in Shp2E76K/+-bearing myeloid cells, in driving JMML. Loss of Morrbid in a mouse model of JMML driven by the Shp2E76K/+ mutation resulted in a significant correction of myeloid and erythroid cell abnormalities associated with JMML, including overall survival. Consistently, patients with JMML who had PTPN11, KRAS, and NRAS mutations and high expression of MORRBID manifested poor overall survival. Our results suggest that Morrbid contributes to JMML pathogenesis.
引用
- Cai Z, Zhang C, Kotzin JJ, et al. Role of lncRNA Morrbid in PTPN11(Shp2)E76K-driven juvenile myelomonocytic leukemia. Blood Adv. 2020. PMID: 32697817. doi:10.1182/bloodadvances.2020002123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。